These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18600840)

  • 21. Optimization of an industrial microalgae fermentation.
    Hilaly AK; Karim MN; Guyre D
    Biotechnol Bioeng; 1994 Feb; 43(4):314-20. PubMed ID: 18615695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature and growth rate effects on the hok/sok killer locus for enhanced plasmid stability.
    Wu K; Jahng D; Wood TK
    Biotechnol Prog; 1994; 10(6):621-9. PubMed ID: 7765697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of specific growth rate on specific productivity and glycosylation of a recombinant avidin produced by a Pichia pastoris Mut+ strain.
    Schenk J; Balazs K; Jungo C; Urfer J; Wegmann C; Zocchi A; Marison IW; von Stockar U
    Biotechnol Bioeng; 2008 Feb; 99(2):368-77. PubMed ID: 17636485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of mathematical model for product formation with recombinant microbes expressed IFN.
    Xu J; Li F; Tang X; Yu J; Liu X
    Chin J Biotechnol; 1997; 13(1):17-23. PubMed ID: 9376502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant protein synthesis and plasmid instability in continuous cultures of Escherichia coli JM103 harboring a high copy number plasmid.
    Ryan W; Parulekar SJ
    Biotechnol Bioeng; 1991 Mar; 37(5):415-29. PubMed ID: 18597388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Productivity improvement of recombinant Escherichia coli fermentation via robust optimization.
    Kavanagh JM; Barton GW
    Bioprocess Biosyst Eng; 2008 Feb; 31(2):137-43. PubMed ID: 17717709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-stage continuous operation of recombinant Escherichia coli using the bacteriophage lambda Q- vector.
    Oh JS; Cho D; Park TH
    Bioprocess Biosyst Eng; 2005 Nov; 28(1):1-7. PubMed ID: 16096763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetic models for the effect of temperature on batch glutathione fermentation by Candida utilis].
    Wei GY; Li Y; Du GC; Chen J
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):358-63. PubMed ID: 15969022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of recombinant human growth hormone in Escherichia coli: expression of different precursors and physiological effects of glucose, acetate, and salts.
    Jensen EB; Carlsen S
    Biotechnol Bioeng; 1990 Jun; 36(1):1-11. PubMed ID: 18592603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid DNA fermentation strategies: influence on plasmid stability and cell physiology.
    Silva F; Queiroz JA; Domingues FC
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2571-80. PubMed ID: 22089386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of plasmid amplification and recombinant gene expression on the growth kinetics of recombinant E. coli.
    Betenbaugh MJ; Beaty C; Dhurjati P
    Biotechnol Bioeng; 1989 May; 33(11):1425-36. PubMed ID: 18587883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous two-stage ABE-fermentation using Clostridium beijerinckii NRRL B592 operating with a growth rate in the first stage vessel close to its maximal value.
    Mutschlechner O; Swoboda H; Gapes JR
    J Mol Microbiol Biotechnol; 2000 Jan; 2(1):101-5. PubMed ID: 10937494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of bacteriophage λ stability using a λQ-S- mutant in the continuous culture of Escherichia coli.
    Oh JS; Choi SS; Park TH
    Bioprocess Biosyst Eng; 2010 Nov; 33(9):1103-7. PubMed ID: 20499104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of recombinant plasmid content on growth properties and cloned gene product formation in Escherichia coli.
    Seo JH; Bailey JE
    Biotechnol Bioeng; 1985 Dec; 27(12):1668-74. PubMed ID: 18553628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes.
    Gnoth S; Simutis R; Lübbert A
    Appl Microbiol Biotechnol; 2010 Aug; 87(6):2047-58. PubMed ID: 20535469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of growth rate effects on productivity of recombinant Escherichia coli populations using molecular mechanism models.
    Lee SB; Bailey JE
    Biotechnol Bioeng; 1984 Jan; 26(1):66-73. PubMed ID: 18551588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics and modeling of temperature-regulated gene product expression in recombinant yeast fermentation.
    Cheng C; Yang ST
    Biotechnol Bioeng; 1996 Jun; 50(6):663-74. PubMed ID: 18627075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of plasmid and expression of a recombinant gonadotropin-releasing hormone (GnRH) vaccine in Escherichia coli.
    Xu J; Li W; Wu J; Zhang Y; Zhu Z; Liu J; Hu Z
    Appl Microbiol Biotechnol; 2006 Dec; 73(4):780-8. PubMed ID: 16896597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proposed feeding strategy for the overproduction of recombinant proteins in Escherichia coli.
    Babaeipour V; Shojaosadati SA; Khalilzadeh R; Maghsoudi N; Tabandeh F
    Biotechnol Appl Biochem; 2008 Feb; 49(Pt 2):141-7. PubMed ID: 17630954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling threshold phenomena, metabolic pathways switches and signals in chemostat-cultivated cells: the Crabtree effect in Saccharomyces cerevisiae.
    Thierie J
    J Theor Biol; 2004 Feb; 226(4):483-501. PubMed ID: 14759654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.